3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs
AI Summary: Researchers at MIT, led by James J. Collins, are utilizing artificial intelligence and quantitative modeling to engineer cells with novel therapeutic properties aimed at addressing global health challenges, including antibiotic resistance. Their collaborative efforts have resulted in the discovery of halicin, a new antibiotic effective against multidrug-resistant bacteria, demonstrating the efficacy of combining AI with systems biology. Recent advancements include the use of generative AI to design new antibiotics from scratch, employing genetic algorithms and variational autoencoders to explore vast chemical spaces. This research underscores the potential of AI-driven approaches in accelerating the development of innovative therapeutics.